Joel Dudley joined Innovation Endeavors as a partner in 2022, overseeing biotech investments. He previously served as Chief Scientific Officer at Tempus and held academic roles at Mount Sinai.
At firms with a similar stage, sector and check size.
One email when Joel's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckJoel Dudley joined Innovation Endeavors as a partner in 2022, overseeing biotech investments. He previously served as Chief Scientific Officer at Tempus and held academic roles at Mount Sinai.
Joel Dudley invests through Innovation Endeavors, which writes checks of $1M to $10M at seed, series a.
Email [email protected], the firm's inbox for founders, and name Joel in the subject. A warm intro from a founder Innovation Endeavors backed works better.
Chief Scientific Officer at Tempus Labs, Inc.; Associate Professor of Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai; Executive Vice President for Precision Health at Mount Sinai Health System.
Last updated 2026-10-15. Is this you? Ask for a correction.